NCT06868732 2025-03-11Evaluation of JSKN016 Combination Therapy in Subjects with NSCLCJiangsu Alphamab Biopharmaceuticals Co., LtdPhase 1 Not yet recruiting288 enrolled
NCT06775483 2025-01-15Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance: a Phase II Clinical StudyJiangsu Alphamab Biopharmaceuticals Co., LtdPhase 2 Not yet recruiting220 enrolled